Integrated Filing — IndAS

General information about company
Scrip Code	512179
NSE Symbol	SUNTECK
MSEI Symbol	NOTLISTED
ISIN	INE805D01034
Name of company	Sunteck Realty Limited
Type of company	Main Board
Class of security	Equity
Date of start of financial year	01-Apr-2024
Date of end of financial year	31-Mar-2025
Date of board meeting when results were approved	02-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange	23-Apr-2025
Description of presentation currency	INR (in Actuals)
Reporting Type	Quarterly
Reporting Quarter	Fourth quarter
Nature of report standalone or consolidated	Standalone
Whether results are audited or unaudited for the quarter ended	Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended	Audited
Segment Reporting	Single segment
Description of single segment	Construction and Development of Real Estate Project
Start date and time of board meeting	02-May-2025   14:45:00
End date and time of board meeting	02-May-2025   16:00:00
Whether cash flow statement is applicable on company	Yes
Type of cash flow statement	Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification	Declaration of unmodified opinion
Whether the company has any related party?	Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure?	Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public	NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure.	NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)?	No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company?	Yes
Latest Date on which RPT policy is updated	2022-05-30
Indicate Company website link for updated RPT policy of the Company	https://www.sunteckindia.com/images/investor/code_Policy/1686135297_Related%20Party%20Transaction%20Policy.pdf
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter?	No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity?	No
The Company has not incurred any default on loans. Further, the Company does not have any debt securities and hence, the same is not applicable to the Company.

Financial Results Ind-AS
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Unaudited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
Part I	Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1	Income
	Revenue from operations	1984588000	8081889000
	Other income	42867000	217657000
	Total income	2027455000	8299546000
2	Expenses
(a)	Cost of materials consumed	360517000	1334491000
(b)	Purchases of stock-in-trade	0	0
(c)	Changes in inventories of finished goods, work-in-progress and stock-in-trade	383594000	3134761000
(d)	Employee benefit expense	183998000	575265000
(e)	Finance costs	112466000	380038000
(f)	Depreciation, depletion and amortisation expense	18399000	76002000
(f)	Other Expenses
1	Other Expenses	247201000	852433000
	Total other expenses	247201000	852433000
	Total expenses	1306175000	6352990000
3	Total profit before exceptional items and tax	721280000	1946556000
4	Exceptional items	0	0
5	Total profit before tax	721280000	1946556000
6	Tax expense
7	Current tax	125894000	260043000
8	Deferred tax	49583000	86426000
9	Total tax expenses	175477000	346469000
10	Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement	0	0
11	Net Profit Loss for the period from continuing operations	545803000	1600087000
12	Profit (loss) from discontinued operations before tax	0	0
13	Tax expense of discontinued operations	0	0
14	Net profit (loss) from discontinued operation after tax	0	0
15	Share of profit (loss) of associates and joint ventures accounted for using equity method	0	0
16	Total profit (loss) for period	545803000	1600087000
17	Other comprehensive income net of taxes	746000	-548000
18	Total Comprehensive Income for the period	546549000	1599539000
19	Total profit or loss, attributable to
	Profit or loss, attributable to owners of parent
	Total profit or loss, attributable to non-controlling interests
20	Total Comprehensive income for the period attributable to
	Comprehensive income for the period attributable to owners of parent
	Total comprehensive income for the period attributable to owners of parent non-controlling interests
21	Details of equity share capital
	Paid-up equity share capital	146489000	146489000
	Face value of equity share capital	1	1
27	Details of debt securities
22	Reserves excluding revaluation reserve		24761244000
23	Earnings per share
i	Earnings per equity share for continuing operations
	Basic earnings (loss) per share from continuing operations	3.73	10.92
	Diluted earnings (loss) per share from continuing operations	3.73	10.92
ii	Earnings per equity share for discontinued operations
	Basic earnings (loss) per share from discontinued operations	0	0
	Diluted earnings (loss) per share from discontinued operations	0	0
ii	Earnings per equity share
	Basic earnings (loss) per share from continuing and discontinued operations	3.73	10.92
	Diluted earnings (loss) per share from continuing and discontinued operations	3.73	10.92
24	Debt equity ratio
25	Debt service coverage ratio
26	Interest service coverage ratio
27	Disclosure of notes on financial results		Please refer notes disclosed in the results uploaded on the Stock Exchanges website. n

Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio

Statement of Asset and Liabilities
Particulars		Year ended (dd-mm-yyyy)
Date of start of reporting period		01-Apr-2024
Date of end of reporting period		31-Mar-2025
Whether results are audited or unaudited		Audited
Nature of report standalone or consolidated		Standalone
	Assets
1	Non-current assets
	Property, plant and equipment	449081000
	Capital work-in-progress	0
	Investment property	3101239000
	Goodwill	0
	Other intangible assets	18100000
	Intangible assets under development	17504000
	Biological assets other than bearer plants	0
	Investments accounted for using equity method	0
	Non-current financial assets
	Non-current investments	10518791000
	Trade receivables, non-current	0
	Loans, non-current	810513000
	Other non-current financial assets	319517000
	Total non-current financial assets	11648821000
	Deferred tax assets (net)	249263000
	Other non-current assets	271976000
	Total non-current assets	15755984000
2	Current assets
	Inventories	8610366000
	Current financial asset
	Current investments	0
	Trade receivables, current	574675000
	Cash and cash equivalents	677034000
	Bank balance other than cash and cash equivalents	384831000
	Loans, current	5005350000
	Other current financial assets	824348000
	Total current financial assets	7466238000
	Current tax assets (net)	0
	Other current assets	1908581000
	Total current assets	17985185000
3	Non-current assets classified as held for sale	0
4	Regulatory deferral account debit balances and related deferred tax Assets	0
	Total assets	33741169000
	Equity and liabilities
1	Equity
	Equity attributable to owners of parent
	Equity share capital	146489000
	Other equity	24761244000
	Total equity attributable to owners of parent	24907733000
	Non controlling interest
	Total equity	24907733000
2	Liabilities
	Non-current liabilities
	Non-current financial liabilities
	Borrowings, non-current	1553691000
	Trade payables, non-current
	(A) Total outstanding dues of micro enterprises and small enterprises	0
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	0
	Total Trade payable	0
	Other non-current financial liabilities	36551000
	Total non-current financial liabilities	1590242000
	Provisions, non-current	19132000
	Deferred tax liabilities (net)	0
	Deferred government grants, Non-current	0
	Other non-current liabilities	82634000
	Total non-current liabilities	1692008000
	Current liabilities
	Current financial liabilities
	Borrowings, current	2314017000
	Trade payables, current
	(A) Total outstanding dues of micro enterprises and small enterprises	149847000
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	1331095000
	Total Trade payable	1480942000
	Other current financial liabilities	120983000
	Total current financial liabilities	3915942000
	Other current liabilities	3163541000
	Provisions, current	40876000
	Current tax liabilities (Net)	21069000
	Deferred government grants, Current	0
	Total current liabilities	7141428000
3	Liabilities directly associated with assets in disposal group classified as held for sale	0
4	Regulatory deferral account credit balances and related deferred tax liability	0
	Total liabilities	8833436000
	Total equity and liabilites	33741169000
	Disclosure of notes on assets and liabilities

Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars		3 months/ 6 month ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period		01-Jan-2025	01-Apr-2024
Date of end of reporting period		31-Mar-2025	31-Mar-2025
Whether accounts are audited or unaudited		Unaudited	Audited
Nature of report standalone or consolidated		Standalone	Standalone
1	Segment Revenue (Income)
	(net sale/income from each segment should be disclosed)
	Total Segment Revenue
	Less: Inter segment revenue
	Revenue from operations
2	Segment Result
	Profit (+) / Loss (-) before tax and interest from each segment
	Total Profit before tax
	i. Finance cost
	ii. Other Unallocable Expenditure net off Unallocable income
	Profit before tax
3	(Segment Asset - Segment Liabilities)
	Segment Asset
	Total Segment Asset
	Un-allocable Assets	null	null
	Net Segment Asset	null	null
4	Segment Liabilities
	Segment Liabilities
	Total Segment Liabilities
	Un-allocable Liabilities	null	null
	Net Segment Liabilities	null	null
	Disclosure of notes on segments

Other Comprehensive Income
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Unaudited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
	Other comprehensive income [Abstract]
1	Amount of items that will not be reclassified to profit and loss
1	Remeasurements of the defined benefit plan	1274000	-552000
2	Gain/(loss) on fair value of equity instruments	45000	45000
	Total Amount of items that will not be reclassified to profit and loss	1319000	-507000
2	Income tax relating to items that will not be reclassified to profit or loss	573000	41000
3	Amount of items that will be reclassified to profit and loss
	Total Amount of items that will be reclassified to profit and loss
4	Income tax relating to items that will be reclassified to profit or loss
5	Total Other comprehensive income	746000	-548000

Cash flow statement, indirect
Particulars				Year ended (dd-mm-yyyy)
A	Date of start of reporting period			2024-04-01
B	Date of end of reporting period			2025-03-31
C	Whether results are audited or unaudited			Unaudited
D	Nature of report standalone or consolidated			Standalone
Part I	Blue color marked fields are non-mandatory.
	Statement of cash flows
	Cash flows from used in operating activities
	Profit before tax			1946556000
	Adjustments for reconcile profit (loss)
	Adjustments for finance costs			380038000
	Adjustments for decrease (increase) in inventories			3228581000
	Adjustments for decrease (increase) in trade receivables, current			1992050000
	Adjustments for decrease (increase) in trade receivables, non-current			0
	Adjustments for decrease (increase) in other current assets			0
	Adjustments for decrease (increase) in other non-current assets			-673853000
	Adjustments for other financial assets, non-current			0
	Adjustments for other financial assets, current			0
	Adjustments for other bank balances			0
	Adjustments for increase (decrease) in trade payables, current			-346500000
	Adjustments for increase (decrease) in trade payables, non-current			0
	Adjustments for increase (decrease) in other current liabilities			0
	Adjustments for increase (decrease) in other non-current liabilities			-2419919000
	Adjustments for depreciation and amortisation expense			76002000
	Adjustments for impairment loss reversal of impairment loss recognised in profit or loss			0
	Adjustments for provisions, current			-26393000
	Adjustments for provisions, non-current			0
	Adjustments for other financial liabilities, current			0
	Adjustments for other financial liabilities, non-current			0
	Adjustments for unrealised foreign exchange losses gains			-1605000
	Adjustments for dividend income			108000
	Adjustments for interest income			76002000
	Adjustments for share-based payments			11268000
	Adjustments for fair value losses (gains)			0
	Adjustments for undistributed profits of associates			0
	Other adjustments for which cash effects are investing or financing cash flow			0
	Other adjustments to reconcile profit (loss)			0
	Other adjustments for non-cash items			-52741000
	Share of profit and loss from partnership firm or association of persons or limited liability partnerships			-1340000
	Total adjustments for reconcile profit (loss)			2089478000
	Net cash flows from (used in) operations			4036034000
	Dividends received			0
	Interest paid			0
	Interest received			0
	Income taxes paid (refund)			503867000
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) operating activities			3532167000
	Cash flows from used in investing activities
	Cash flows from losing control of subsidiaries or other businesses			0
	Cash flows used in obtaining control of subsidiaries or other businesses			0
	Other cash receipts from sales of equity or debt instruments of other entities			4703000
	Other cash payments to acquire equity or debt instruments of other entities			796281000
	Other cash receipts from sales of interests in joint ventures			0
	Other cash payments to acquire interests in joint ventures			0
	Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships			0
	Cash payment for investment in partnership firm or association of persons or limited liability partnerships			111401000
	Proceeds from sales of property, plant and equipment			1086000
	Purchase of property, plant and equipment			118827000
	Proceeds from sales of investment property			0
	Purchase of investment property			0
	Proceeds from sales of intangible assets			0
	Purchase of intangible assets			0
	Proceeds from sales of intangible assets under development			0
	Purchase of intangible assets under development			0
	Proceeds from sales of goodwill			0
	Purchase of goodwill			0
	Proceeds from biological assets other than bearer plants			0
	Purchase of biological assets other than bearer plants			0
	Proceeds from government grants			0
	Proceeds from sales of other long-term assets			0
	Purchase of other long-term assets			0
	Cash advances and loans made to other parties			216848000
	Cash receipts from repayment of advances and loans made to other parties			337259000
	Cash payments for future contracts, forward contracts, option contracts and swap contracts			0
	Cash receipts from future contracts, forward contracts, option contracts and swap contracts			0
	Dividends received			108000
	Interest received			76990000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			-1835540000
	Net cash flows from (used in) investing activities	-2658751000
	Cash flows from used in financing activities
	Proceeds from changes in ownership interests in subsidiaries			0
	Payments from changes in ownership interests in subsidiaries			0
	Proceeds from issuing shares			0
	Proceeds from issuing other equity instruments			0
	Payments to acquire or redeem entity's shares			0
	Payments of other equity instruments			0
	Proceeds from exercise of stock options			600000
	Proceeds from issuing debentures notes bonds etc			0
	Proceeds from borrowings			1297194000
	Repayments of borrowings			1740870000
	Payments of lease liabilities			0
	Dividends paid			219828000
	Interest paid			0
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			-343186000
	Net cash flows from (used in) financing activities			-1006090000
	Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes			-132674000
	Effect of exchange rate changes on cash and cash equivalents
	Effect of exchange rate changes on cash and cash equivalents			-1000
	Net increase (decrease) in cash and cash equivalents			-132675000
	Cash and cash equivalents cash flow statement at beginning of period			22462000
	Cash and cash equivalents cash flow statement at end of period			-110213000